Anzeige
Mehr »
Login
Sonntag, 22.12.2024 Börsentäglich über 12.000 News von 679 internationalen Medien
Breaking News: Vorweihnachtlicher Kaufrausch an der Börse?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0LA7D | ISIN: CA65337X1042 | Ticker-Symbol:
Branche
Dienstleistungen
Aktienmarkt
Sonstige
1-Jahres-Chart
NEXGENRX INC Chart 1 Jahr
5-Tage-Chart
NEXGENRX INC 5-Tage-Chart

Aktuelle News zur NEXGENRX Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
26.11.NexgenRx Inc.: NexgenRx Announces Third Quarter Results and Declaration of Divdend262TORONTO, ON / ACCESSWIRE / November 25, 2024 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its financial results for the third quarter ended September 30, 2024, with quarterly...
► Artikel lesen
NEXGENRX Aktie jetzt für 0€ handeln
08.10.NexgenRx Inc: NexgenRx reappoints Burns to board2
07.10.NexgenRx, Inc.: NexgenRX Announces Director Re-Appointment255TORONTO, ON / ACCESSWIRE / October 7, 2024 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce the re-appointment of Charles Burns to its Board of Directors effective immediately. Mr....
► Artikel lesen
01.10.NexgenRx Inc: NexgenRx appoints Brennan as director3
01.10.NexgenRx Inc.: NexgenRx Announces New Director139TORONTO, ON / ACCESSWIRE / October 1, 2024 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce the appointment of Linda Brennan to its Board of Directors effective immediately.Linda...
► Artikel lesen
15.08.NexgenRx, Inc.: NexgenRx Announces Second Quarter Results, With Over 19% Revenue Growth and Positive EBITDA529TORONTO, ON / ACCESSWIRE / August 15, 2024 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its financial results for the second quarter ended June 30, 2024, with quarterly revenue...
► Artikel lesen
24.07.NexgenRx Inc: NexgenRx 781,249 shares for debt1
18.07.NexgenRx Inc: NexgenRx issues 195,312 shares to PBM Management1
18.07.NexgenRx, Inc.: NexgenRx Announces Share Issuances Under Consulting Agreement275TORONTO, ON / ACCESSWIRE / July 18, 2024 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce the issuance of an aggregate of 195,312 common shares at a price of $0.32 in respect of...
► Artikel lesen
14.06.NexgenRx Inc.: NexgenRx Announces Declaration of Dividend314NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce that a dividend in the amount of one-half of one cent per share ($0.005) has been declared in respect of all of its outstanding common...
► Artikel lesen
17.05.NexgenRx Inc.: NexgenRx Announces First Quarter Results, with 24% Revenue Growth and Record Earnings428TORONTO, ON / ACCESSWIRE / May 17, 2024 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its financial results for the first quarter ended March 31, 2024, with revenue of $4,292...
► Artikel lesen
17.05.NexgenRx Inc.: NexgenRx Announces Annual Meeting Results703TORONTO, ON / ACCESSWIRE / May 16, 2024 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce the results of its annual and special meeting (the "Meeting") of shareholders, which was...
► Artikel lesen
06.04.NexgenRx Inc.: NexgenRx Announces 2023 Year End Results With Solid Revenue Growth, Continuing Positive EBITDA777TORONTO, ON / ACCESSWIRE / April 5, 2024 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its annual financial results for the financial year ended December 31, 2023, with continued...
► Artikel lesen
29.12.23NexgenRx Inc.: NexgenRx Announces Director Resignation511TORONTO, ON / ACCESSWIRE / December 29, 2023 / NEXGENRX INC. ("NexgenRx" or the "Company") announces the retirement of Dave Bennett from its Board of Directors as he has accepted a senior executive...
► Artikel lesen
14 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1